Proteome Sciences plc (PMSNF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.63 Million USD | 362.04% |
| 2022 | 353 Thousand USD | -41.36% |
| 2021 | 602 Thousand USD | 67.69% |
| 2020 | 359 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - GBP | 0.0% |
| 2017 | - GBP | -100.0% |
| 2016 | 166 Thousand GBP | -56.99% |
| 2015 | 386 Thousand GBP | 0.0% |
| 2014 | - GBP | 0.0% |
| 2013 | - GBP | 0.0% |
| 2012 | - GBP | 0.0% |
| 2011 | - GBP | 0.0% |
| 2010 | - GBP | 0.0% |
| 2009 | - GBP | 0.0% |
| 2008 | - GBP | 0.0% |
| 2007 | - GBP | 0.0% |
| 2006 | - GBP | 0.0% |
| 2005 | - GBP | 0.0% |
| 2004 | - GBP | 0.0% |
| 2003 | - GBP | -100.0% |
| 2002 | 33 Thousand GBP | -67.33% |
| 2001 | 101 Thousand GBP | 260.71% |
| 2000 | 28 Thousand GBP | -15.15% |
| 1999 | 33 Thousand GBP | 153.85% |
| 1998 | 13 Thousand GBP | 0.0% |
| 1997 | - GBP | -100.0% |
| 1996 | 1000.00 GBP | -95.0% |
| 1995 | 20 Thousand GBP | 0.0% |
| 1994 | - GBP | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2023 Q4 | 1.63 Million USD | -18.03% |
| 2023 Q3 | 1.98 Million GBP | 910.08% |
| 2023 Q1 | 243.03 Thousand GBP | -31.15% |
| 2023 FY | 1.63 Million USD | 362.04% |
| 2023 Q2 | 197 Thousand USD | -18.94% |
| 2022 Q3 | 394.19 Thousand GBP | -17.7% |
| 2022 Q2 | 479 Thousand GBP | -23.87% |
| 2022 Q4 | 353 Thousand USD | -10.45% |
| 2022 Q1 | 629.21 Thousand GBP | 4.52% |
| 2022 FY | 353 Thousand USD | -41.36% |
| 2021 Q3 | 811.21 Thousand GBP | 0.0% |
| 2021 Q1 | - GBP | -100.0% |
| 2021 FY | 602 Thousand USD | 67.69% |
| 2021 Q4 | 602 Thousand GBP | -25.79% |
| 2021 Q2 | - GBP | 0.0% |
| 2020 Q3 | 463.22 Thousand GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2020 Q2 | - GBP | 0.0% |
| 2020 Q4 | 359 Thousand GBP | -22.5% |
| 2020 FY | 359 Thousand USD | 0.0% |
| 2019 Q2 | - GBP | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q1 | - GBP | 0.0% |
| 2019 Q4 | - GBP | 0.0% |
| 2019 Q3 | - GBP | 0.0% |
| 2018 FY | - GBP | 0.0% |
| 2018 Q2 | - GBP | 0.0% |
| 2018 Q1 | - GBP | 0.0% |
| 2018 Q3 | - GBP | 0.0% |
| 2018 Q4 | - GBP | 0.0% |
| 2017 Q4 | - GBP | 0.0% |
| 2017 Q3 | - GBP | -100.0% |
| 2017 Q2 | 101 Thousand GBP | -20.19% |
| 2017 FY | - GBP | -100.0% |
| 2017 Q1 | 126.55 Thousand GBP | -23.77% |
| 2016 Q1 | 358.63 Thousand GBP | -7.09% |
| 2016 Q4 | 166 Thousand GBP | -22.86% |
| 2016 Q2 | 249 Thousand GBP | -30.57% |
| 2016 FY | 166 Thousand GBP | -56.99% |
| 2016 Q3 | 215.19 Thousand GBP | -13.58% |
| 2015 Q4 | 386 Thousand GBP | -33.91% |
| 2015 Q1 | - GBP | 0.0% |
| 2015 FY | 386 Thousand GBP | 0.0% |
| 2015 Q3 | 584.09 Thousand GBP | 0.0% |
| 2015 Q2 | - GBP | 0.0% |
| 2014 Q3 | - GBP | 0.0% |
| 2014 FY | - GBP | 0.0% |
| 2014 Q2 | - GBP | 0.0% |
| 2014 Q1 | - GBP | 0.0% |
| 2014 Q4 | - GBP | 0.0% |
| 2013 FY | - GBP | 0.0% |
| 2013 Q2 | - GBP | 0.0% |
| 2013 Q1 | - GBP | 0.0% |
| 2013 Q4 | - GBP | 0.0% |
| 2013 Q3 | - GBP | 0.0% |
| 2012 Q4 | - GBP | 0.0% |
| 2012 FY | - GBP | 0.0% |
| 2012 Q2 | - GBP | 0.0% |
| 2011 FY | - GBP | 0.0% |
| 2011 Q4 | - GBP | 0.0% |
| 2011 Q2 | - GBP | 0.0% |
| 2010 Q4 | - GBP | 0.0% |
| 2010 Q2 | - GBP | 0.0% |
| 2010 FY | - GBP | 0.0% |
| 2009 Q2 | - GBP | 0.0% |
| 2009 FY | - GBP | 0.0% |
| 2009 Q4 | - GBP | 0.0% |
| 2008 FY | - GBP | 0.0% |
| 2008 Q4 | - GBP | 0.0% |
| 2008 Q2 | - GBP | 0.0% |
| 2007 Q2 | - GBP | 0.0% |
| 2007 FY | - GBP | 0.0% |
| 2007 Q4 | - GBP | 0.0% |
| 2006 Q4 | - GBP | 0.0% |
| 2006 Q2 | - GBP | 0.0% |
| 2006 FY | - GBP | 0.0% |
| 2005 Q2 | - GBP | 0.0% |
| 2005 Q4 | - GBP | 0.0% |
| 2005 FY | - GBP | 0.0% |
| 2004 Q2 | - GBP | 0.0% |
| 2004 Q4 | - GBP | 0.0% |
| 2004 FY | - GBP | 0.0% |
| 2003 FY | - GBP | -100.0% |
| 2002 FY | 33 Thousand GBP | -67.33% |
| 2001 FY | 101 Thousand GBP | 260.71% |
| 2000 FY | 28 Thousand GBP | -15.15% |
| 1999 FY | 33 Thousand GBP | 153.85% |
| 1998 FY | 13 Thousand GBP | 0.0% |
| 1997 FY | - GBP | -100.0% |
| 1996 FY | 1000.00 GBP | -95.0% |
| 1995 FY | 20 Thousand GBP | 0.0% |
| 1994 FY | - GBP | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -27083.333% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -25.702% |
| Biocept, Inc. | 10.37 Million USD | 84.28% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 96.821% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 97.336% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -198.541% |
| iMD Companies, Inc. | 1.1 Million USD | -47.78% |
| IDenta Corp. | 428.17 Thousand USD | -280.918% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 61.56% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -486.691% |
| NovelStem International Corp. | 3.32 Million USD | 50.941% |
| Optigenex Inc. | 4.42 Million USD | 63.158% |
| PharmChem, Inc. | - USD | -Infinity% |
| Response Genetics, Inc | 4.91 Million USD | 66.836% |
| Rennova Health, Inc. | 359.19 Thousand USD | -354.073% |
| RushNet, Inc. | 4.25 Million USD | 61.645% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -554.889% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -104.273% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -182.972% |
| Todos Medical Ltd. | 33 Million USD | 95.058% |